NCT05623046

Brief Summary

To examine the feasibility, acceptability, and preliminary efficacy of a remotely delivered intervention for civilians and service members with mild traumatic brain injury (mTBI) who have difficulty recognizing and regulating their emotions. Post-treatment outcomes of interest include emotional self-awareness and regulation, resiliency, and affective symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 21, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

February 23, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2025

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

2.1 years

First QC Date

November 14, 2022

Last Update Submit

March 26, 2025

Conditions

Keywords

AlexithymiaBrain InjuryConcussionEmotion DysregulationAffectResilienceMilitaryService MembersMoodTeletherapy

Outcome Measures

Primary Outcomes (1)

  • Change in Toronto Alexithymia Scale-20 (TAS-20)

    This is a 20-item self report questionnaire comprised of three sub-constructs (Difficulty Identifying feelings, Difficulty Describing feelings, Externally-oriented Thinking). The full scale range is 20-100 (higher scores indicate higher (worse) alexithymia). Subscales are summed to compute a total score.

    Baseline, Week 6, Week 12, Week 24

Secondary Outcomes (2)

  • Change in Levels of Emotional Awareness Scale (LEAS)

    Baseline, Week 6, Week 12, Week 24

  • Change in Difficulty with Emotion Regulation Scale (DERS)

    Baseline, Week 6, Week 12, Week 24

Other Outcomes (22)

  • Change in Brief Resilience Scale (BRS)

    Baseline, Week 6, Week 12, Week 24

  • Change in Positive and Negative Affect Schedule (PANAS)

    Baseline, Week 6, Week 12, Week 24

  • Change in Patient Health Questionnaire-9 (PHQ-9)

    Baseline, Week 6, Week 12, Week 24

  • +19 more other outcomes

Study Arms (1)

Treatment

EXPERIMENTAL

8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes.

Behavioral: Treatment

Interventions

TreatmentBEHAVIORAL

8 one-on-one teletherapy training sessions to enhance emotional skills. Teletherapy sessions will last approximately 60-90 minutes

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mild TBI (determined by Ohio State University TBI Identification Method)
  • ≥18 years old
  • ≥6 months post-TBI
  • elevated alexithymia and emotion dysregulation (defined by \>.5 standard deviation above means on the TAS-20 and DERS)
  • capacity to consent
  • proficient English
  • if on medications that influence affect, must be stable for at least 6 weeks
  • access to a device capable of video conferencing and high speed internet.

You may not qualify if:

  • Premorbid neurological disorder other than TBI (e.g., stroke), active or uncontrolled major psychiatric disorder and/ or disorder that would pose a safety concern (e.g., borderline personality disorder)
  • degenerative neurologic condition
  • visual, hearing, communication, or cognitive impairments that would impede participation
  • unstable or anticipated medication changes that will influence mood/ affect during study participation
  • active involvement in an intensive rehabilitation program
  • individuals who recently started psychotherapy (e.g., \< 3 months ago)
  • participant behaviors that cause concern for their ability to participate in accordance with the study requirements and protocol (e.g., unreliable correspondences, no-shows, no-replies to multiple contacts, habitual rescheduling, unable to complete study requirements in timely manner)
  • participants will be excluded if at any point, they participated in TREAT (in-person clinical trial of BEST - NCT03414463)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Brain ConcussionSyndromeAffective SymptomsBrain Injuries

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingDiseasePathologic ProcessesPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Flora Hammond, MD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair of Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

November 14, 2022

First Posted

November 21, 2022

Study Start

February 23, 2023

Primary Completion

March 13, 2025

Study Completion

March 25, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Locations